Skip to main content
Home
Member Login RDCRN Network Site

Header Social Media

  • Our Research
    • Research Studies
    • Clinical Sites
    • CEGIR Publications
    • CEGIR-Related Publications
    • Diseases Studied
  • Patients and Families
    • Patient Advocacy Groups
    • Resources for Patients and Families
    • Frequently Asked Questions
    • Glossary
  • Researchers and Clinicians
    • Resources For Researchers and Clinicians
    • Collaborate With Us
    • Disorder Definitions
    • Funding Opportunities
    • Treatment Guidelines
  • Early Stage Investigators
    • Funding Opportunities
    • Pilot and Feasibility Grants
    • Scholar Awards
    • Meet Our Early Stage Investigators
    • Previous Trainees/Scholars
  • News and Events
    • Latest News
    • Past Events
    • Newsletter
  • About Us
    • Our Consortium
    • Meet Our Team
    • Goals, Mission & Vision
    • Contact Us
An NIH-Funded Rare Diseases Clinical Research Network Consortium

Latest News

Rare Research Report: January 2023

Each month, we share summaries of recent Rare Diseases Clinical Research Network (RDCRN) grant-funded publications. Catch up on the latest RDCRN research. 

Read More
Rare Research Report logo

Training Program for Clinical Research in Rare Disease Launches New Session

November 9 2022

Read More
Screenshot from a presentation on the Rare Diseases Research R25 Curriculum Grant

Rare Research Report: September 2022

September 7 2022

Read More
Rare Research Report logo

Rare Research Report: August 2022

August 17 2022

Read More
Rare Research Report logo

RDCRN Research Roundup: July 2022

July 6 2022

Read More
Rare Diseases Clinical Research Network logo with text: Research Roundup, #RDCRN

Development of Outcome Metrics Leads to First FDA-Approved Treatment for Eosinophilic Esophagitis

June 27 2022

Read More
CEGIR members gathering in 2020

Congenital Absence of MUC5B Defines New Category of Genetic Respiratory Disease and More: RDCRN Research Roundup

April 18 2022

Read More
Scientist examining samples in the lab

RDCRN Research Roundup: April 2022

April 4 2022

Read More
Research Roundup. #RareDiseasesSpotlight. Rare Diseases Clinical Research Network

RDCRN Launches Contact Registry to Connect Patients, Researchers and Advance Rare Disease Research

March 14 2022

Read More
Three icons featuring a trio of silhouettes, a chemistry flask and stethoscope, and a contact card appear next to the text, Join Our Contact Registry - Learn about opportunities to participate in our research, receive information about our work, connect with our consortia and patient advocacy groups. rdcrn.org/registry appears next to the Rare Diseases Clinical Research Network logo
  • Load More
Join Our Email List
Recent Tweets

Footer

  • Web Policies
  • Rare Diseases Clinical Research Network
  • Genetic and Rare Diseases Information Center
  • Members Login
  • Contact Us

The Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) is part of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Division of Rare Diseases Research Innovation (DRDRI). CEGIR is funded under grant number U54AI117804 as a collaboration between NCATS, the National Institute of Allergy and Infectious Diseases (NIAID), and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This website is hosted by the network’s Data Management and Coordinating Center at Cincinnati Children’s Hospital Medical Center, which is funded by NCATS and the National Institute of Neurological Disorders and Stroke (NINDS) under grant number TR002818. The content of this website is solely the responsibility of the CEGIR administrative coordinating center at Cincinnati Children’s Hospital Medical Center and does not necessarily represent the official views of the NIH.

social media